These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial. Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071 [TBL] [Abstract][Full Text] [Related]
3. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus. Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908 [TBL] [Abstract][Full Text] [Related]
4. Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure. Ivanes F; Susen S; Mouquet F; Pigny P; Cuilleret F; Sautière K; Collet JP; Beygui F; Hennache B; Ennezat PV; Juthier F; Richard F; Dallongeville J; Hillaert MA; Doevendans PA; Jude B; Bertrand M; Montalescot G; Van Belle E Eur Heart J; 2012 Jan; 33(2):191-202. PubMed ID: 21719456 [TBL] [Abstract][Full Text] [Related]
5. Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study. Brozaitiene J; Mickuviene N; Podlipskyte A; Burkauskas J; Bunevicius R BMC Cardiovasc Disord; 2016 Feb; 16():45. PubMed ID: 26892923 [TBL] [Abstract][Full Text] [Related]
6. Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function. Palazzuoli A; Deckers J; Calabrò A; Campagna MS; Nuti R; Pastorelli M; Pasqui AL; Bruni F; Auteri A; Puccetti L Am J Cardiol; 2006 Nov; 98(10):1322-8. PubMed ID: 17134622 [TBL] [Abstract][Full Text] [Related]
7. Prognostic accuracy of B-natriuretic peptide measurements and coronary artery calcium in asymptomatic subjects (from the Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research [EISNER] study). Shaw LJ; Polk DM; Kahute TA; Wong ND; Moon J; Miranda-Peats R; Rozanski A; Friedman JD; Hayes S; Thomson L; Berman DS Am J Cardiol; 2009 Nov; 104(9):1245-50. PubMed ID: 19840570 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E; J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of B-type natriuretic peptide for cardiovascular events independent of left ventricular end-diastolic pressure. Rogers RK; May HT; Anderson JL; Muhlestein JB Am Heart J; 2009 Nov; 158(5):777-83. PubMed ID: 19853697 [TBL] [Abstract][Full Text] [Related]
10. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes. Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558 [TBL] [Abstract][Full Text] [Related]
11. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide. Lyngbæk S; Winkel P; Gøtze JP; Kastrup J; Gluud C; Kolmos HJ; Kjøller E; Jensen GB; Hansen JF; Hildebrandt P; Hilden J; Eur J Prev Cardiol; 2014 Oct; 21(10):1275-84. PubMed ID: 23723326 [TBL] [Abstract][Full Text] [Related]
12. C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization. Stone PA; Schlarb H; Campbell JE; Williams D; Thompson SN; John M; Campbell JR; AbuRahma AF J Vasc Surg; 2014 Sep; 60(3):652-60. PubMed ID: 24795153 [TBL] [Abstract][Full Text] [Related]
13. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654 [TBL] [Abstract][Full Text] [Related]
14. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Omland T; Persson A; Ng L; O'Brien R; Karlsson T; Herlitz J; Hartford M; Caidahl K Circulation; 2002 Dec; 106(23):2913-8. PubMed ID: 12460871 [TBL] [Abstract][Full Text] [Related]
15. B-type natriuretic peptide predicts stroke of presumable cardioembolic origin in addition to coronary artery calcification. Kara K; Gronewold J; Neumann T; Mahabadi AA; Weimar C; Lehmann N; Berger K; Kälsch HI; Bauer M; Broecker-Preuss M; Möhlenkamp S; Moebus S; Jöckel KH; Erbel R; Hermann DM Eur J Neurol; 2014 Jun; 21(6):914-21. PubMed ID: 24661834 [TBL] [Abstract][Full Text] [Related]
16. Predicting risk of coronary events and all-cause mortality: role of B-type natriuretic peptide above traditional risk factors and coronary artery calcium scoring in the general population: the Heinz Nixdorf Recall Study. Kara K; Mahabadi AA; Berg MH; Lehmann N; Möhlenkamp S; Kälsch H; Bauer M; Moebus S; Dragano N; Jöckel KH; Neumann T; Erbel R Eur J Prev Cardiol; 2014 Sep; 21(9):1171-9. PubMed ID: 23674833 [TBL] [Abstract][Full Text] [Related]
17. Peripheral endothelial function and cardiovascular events in high-risk patients. Matsuzawa Y; Sugiyama S; Sumida H; Sugamura K; Nozaki T; Ohba K; Matsubara J; Kurokawa H; Fujisue K; Konishi M; Akiyama E; Suzuki H; Nagayoshi Y; Yamamuro M; Sakamoto K; Iwashita S; Jinnouchi H; Taguri M; Morita S; Matsui K; Kimura K; Umemura S; Ogawa H J Am Heart Assoc; 2013 Nov; 2(6):e000426. PubMed ID: 24275629 [TBL] [Abstract][Full Text] [Related]
18. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus. Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896 [TBL] [Abstract][Full Text] [Related]
19. N-terminal pro-B-type natriuretic peptide predicts total and cardiovascular mortality in individuals with or without stable coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study. März W; Tiran B; Seelhorst U; Wellnitz B; Bauersachs J; Winkelmann BR; Boehm BO; Clin Chem; 2007 Jun; 53(6):1075-83. PubMed ID: 17446333 [TBL] [Abstract][Full Text] [Related]
20. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]